12 investment signals defining the 2026 bio-manufacturing boom

ha aggiunto una foto Farkındalık Uygulamaları

2026-02-24 10:12:11 -

Investors in 2026 are pivoting away from traditional pharma to focus on the "Bio-Infrastructure" layer—the companies that provide the reagents, robots, and AI software required to scale 3D tissue production. As the market for organoids and spheroids reaches a critical mass, the focus has shifted toward high-margin recurring revenue models in the consumables space. From synthetic hydrogels...

0 Commenti 0 condivisioni 367 Views 0 Anteprima